Product Information

PHOSPHA 250 NEUTRAL TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5735 per EA under NDC 64980010401. Its NADAC has been published 673 times since Nov 28, 2013.

Strength

155; 852; 130 mg/1; mg/1; mg/1

NDC

64980010401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Unapproved

On Market Since

6/28/2012

Price Statistics

The NADAC for PHOSPHA 250 NEUTRAL TABLET has been published 673 times since Nov 28, 2013, and over the history we have for it it has risen 307.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5735 per EA
All-time high$0.5735 (Nov 18, 2026)
All-time low$0.1406 (Nov 28, 2013)
52-week high$0.5735
52-week low$0.2116
Median price$0.2522
Average price$0.2590
Largest weekly change+59.1% (Jan 22, 2014)
Weeks tracked673
Tracking sinceNov 28, 2013

Price History

1W

+14.2%

1M

+44.3%

3M

+82.4%

6M

+97.7%

1Y

+171.1%

3Y

+205.5%

5Y

+137.5%

All

+307.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PHOSPHA 250 NEUTRAL TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHOSPHA 250 NEUTRAL TABLET, manufactured by Rising Pharma Holdings Inc., is $0.5735 per EA (NDC 64980010401), effective Nov 18, 2026.

How has the price of PHOSPHA 250 NEUTRAL TABLET changed over time?

Over the history we have for it, the NADAC for PHOSPHA 250 NEUTRAL TABLET has risen 307.8%. It has been tracked across 673 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PHOSPHA 250 NEUTRAL TABLET?

Since Nov 28, 2013, the NADAC for PHOSPHA 250 NEUTRAL TABLET has ranged from a low of $0.1406 (Nov 28, 2013) to a high of $0.5735 (Nov 18, 2026), with a median of $0.2522 per EA.

Are there cheaper alternatives to PHOSPHA 250 NEUTRAL TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PHOSPHA 250 NEUTRAL TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PHOSPHA 250 NEUTRAL TABLET?

PHOSPHA 250 NEUTRAL TABLET (NDC 64980010401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.